ImageneBio, Inc. SEC filings IMA
ImageneBio, Inc. has 336 filings in SEC EDGAR's recent list, going back to Jan 8, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| EFFECT | Filing | Aug 11, 2026 | — |
| EFFECT | Filing | Aug 11, 2026 | — |
| EFFECT | Filing | Aug 6, 2026 | — |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| S-3 | Shelf registration | Aug 5, 2026 | — |
| POS AM | Filing | Aug 5, 2026 | — |
| 424B3 | Prospectus | Aug 5, 2026 | — |
| S-3 | Shelf registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 3 | Initial insider ownership | Jul 28, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 25, 2026 |
| 424B3 | Prospectus | Jul 23, 2026 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 23, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 16, 2026 |
| 424B3 | Prospectus | Jun 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jun 26, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 16, 2026 |
| 424B3 | Prospectus | Jun 17, 2026 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 424B3 | Prospectus | May 8, 2026 | — |
| 424B3 | Prospectus | May 7, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 16, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 29, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 21, 2026 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 21, 2026 | — |
| 3 | Initial insider ownership | Apr 20, 2026 | Mar 20, 2026 |
| 3 | Initial insider ownership | Apr 16, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 424B3 | Prospectus | Apr 13, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 13, 2026 | Apr 12, 2026 |
| EFFECT | Filing | Apr 3, 2026 | — |
| POS AM | Filing | Apr 2, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2026 | Mar 12, 2026 |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 3 | Initial insider ownership | Feb 20, 2026 | Feb 16, 2026 |
| 424B3 | Prospectus | Feb 17, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Feb 17, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 6, 2026 | — |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 24, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 424B3 | Prospectus | Dec 18, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 18, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 19, 2025 | Nov 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 424B3 | Prospectus | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 3 | Initial insider ownership | Nov 7, 2025 | Nov 1, 2025 |
| 424B3 | Prospectus | Nov 5, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Nov 5, 2025 | Nov 1, 2025 |
| 424B3 | Prospectus | Oct 30, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Oct 29, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 10, 2025 | Oct 10, 2025 |
| 4 | Insider transaction | Oct 10, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Oct 10, 2025 | Jul 25, 2025 |
| EFFECT | Filing | Sep 15, 2025 | — |
| CORRESP | Letter to the SEC | Sep 11, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| S-1 | Registration statement | Sep 8, 2025 | — |
| 4 | Insider transaction | Aug 15, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Aug 15, 2025 | Jul 25, 2025 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Aug 12, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Aug 7, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Aug 7, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 5, 2025 | Aug 2, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 4, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 4, 2025 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 1, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 25, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 30, 2025 | — |
| 4 | Insider transaction | Jul 30, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Jul 29, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Jul 29, 2025 | Jul 25, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 29, 2025 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 29, 2025 | Jul 25, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 28, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 25, 2025 | Jul 25, 2025 |
| 10-Q | Quarterly report | Jul 24, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jul 24, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Other events
|
Jul 22, 2025 | Jul 22, 2025 |
| D | Filing | Jul 18, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jul 16, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results, Other events
|
Jul 15, 2025 | Jul 15, 2025 |
| 425 | Filing | Jul 11, 2025 | — |
| 8-K |
Current report
Other events
|
Jul 11, 2025 | Jul 11, 2025 |
| 425 | Filing | Jul 1, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 1, 2025 | Jul 1, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jun 18, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Jun 16, 2025 | — |
| EFFECT | Filing | Jun 11, 2025 | — |
| 424B3 | Prospectus | Jun 11, 2025 | — |
| CORRESP | Letter to the SEC | Jun 10, 2025 | — |
| S-4/A | Filing | Jun 9, 2025 | — |
| CORRESP | Letter to the SEC | Jun 9, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2025 | — |
| S-4/A | Filing | May 30, 2025 | — |
| S-4/A | Filing | May 20, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| CORRESP | Letter to the SEC | May 7, 2025 | — |
| S-4/A | Filing | May 7, 2025 | — |
| UPLOAD | Letter from the SEC | May 2, 2025 | — |
| CORRESP | Letter to the SEC | Apr 21, 2025 | — |
| S-4/A | Filing | Apr 21, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2025 | — |
| S-4 | Registration for a merger or exchange | Mar 18, 2025 | — |
| ARS | Annual report to shareholders | Mar 6, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 6, 2025 | Dec 31, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 425 | Filing | Jan 10, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 31, 2024 | — |
| 425 | Filing | Dec 23, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
|
Dec 23, 2024 | Dec 23, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 12, 2024 | Jul 8, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 4 | Insider transaction | Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure, Other events
|
May 28, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 7, 2024 |
| S-8 | Employee stock plan registration | Mar 12, 2024 | — |
| 10-K | Annual report | Mar 12, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Mar 5, 2024 | Mar 1, 2024 |
| 3 | Initial insider ownership | Mar 5, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 21, 2024 | Feb 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 4 | Insider transaction | Feb 2, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Regulation FD disclosure, Other events
|
Jan 18, 2024 | Jan 17, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| SC 13G | Ownership over 5% (passive) | Oct 19, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 11, 2023 | Oct 11, 2023 |
| DEF 14A | Proxy statement | Sep 25, 2023 | Oct 11, 2023 |
| 4/A | Filing | Sep 21, 2023 | Aug 4, 2023 |
| 4/A | Filing | Sep 21, 2023 | Aug 4, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 21, 2023 | — |
| PRE 14A | Preliminary proxy statement | Sep 15, 2023 | Sep 15, 2023 |
| 4 | Insider transaction | Sep 14, 2023 | Aug 4, 2023 |
| 4 | Insider transaction | Sep 14, 2023 | Aug 4, 2023 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 14, 2023 | — |
| 424B5 | Prospectus supplement | Sep 12, 2023 | — |
| EFFECT | Filing | Sep 8, 2023 | — |
| CORRESP | Letter to the SEC | Sep 6, 2023 | — |
| D | Filing | Aug 18, 2023 | — |
| S-3 | Shelf registration | Aug 18, 2023 | — |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 7, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 30, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 9, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 9, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 9, 2023 |
| 4 | Insider transaction | Jun 13, 2023 | Jun 9, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1835579
- Former names
- Ikena Oncology, Inc. (until Jul 25, 2025)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.